📰 Rob Winder News
Page 4 - Rob Winder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Winder. Real-time updates on events, politics, business and more.
December 7, 2021
Investegate announcements from PureTech Health PLC, PRTCs Lymphatic Platform Candidate Human Study
December 1, 2021
Investegate announcements from PureTech Health PLC, PRTC: Gelesis Plenity Now Broadly Available in US
October 14, 2021
Investegate announcements from PureTech Health PLC, PRTCs Vedanta Appoints Chief Legal Officer
August 17, 2021
Investegate announcements from PureTech Health PLC, Akili Deal Furthers Digital Medicine Leadership
August 13, 2021
Investegate announcements from PureTech Health PLC, PRTC Appoints Industry Veteran & Physician as CMO
August 11, 2021
Investegate announcements from PureTech Health PLC, PRTC Receives $6.5M; Imbrium to Develop LYT-503
May 27, 2021
Investegate announcements from PureTech Health PLC, PureTechs Gelesis Presents Plenity Data at AACE
May 26, 2021
Investegate announcements from PureTech Health PLC, PureTechs Akili Secures $160M in Financing
April 28, 2021
Preclinical research suggests that restoring lymphatic flow in the brain has the potential to address a range of neurodegenerative diseases, such as Alzheimers and Parkinsons diseases, and associated neuroinflammation Additionally, research found that improving lymphatic flow could enhance the efficacy of antibody therapies against aberrant proteins, potentially opening a new avenue for disease management PureTech Health plc (Nasdaq: PRTC, LSE: PR...
April 15, 2021
PureTech Announces Annual Results for Year Ended December 31, 2020 By Staff 2 seconds ago Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021 3 ($403.9 million as of December 31, 2020 4) Advancement of Wholly Owned Pipeline with four clinical trial initiations...